164 related articles for article (PubMed ID: 11390590)
21. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus.
Lee H; Guo J; Li M; Choi JK; DeMaria M; Rosenzweig M; Jung JU
Mol Cell Biol; 1998 Sep; 18(9):5219-28. PubMed ID: 9710606
[TBL] [Abstract][Full Text] [Related]
22. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines.
Zoeteweij JP; Rinderknecht AS; Davis DA; Yarchoan R; Blauvelt A
J Med Virol; 2002 Mar; 66(3):378-83. PubMed ID: 11793390
[TBL] [Abstract][Full Text] [Related]
23. Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Liang Q; Chang B; Lee P; Brulois KF; Ge J; Shi M; Rodgers MA; Feng P; Oh BH; Liang C; Jung JU
J Virol; 2015 May; 89(10):5308-17. PubMed ID: 25740994
[TBL] [Abstract][Full Text] [Related]
24. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein.
Lee BS; Connole M; Tang Z; Harris NL; Jung JU
J Virol; 2003 Jul; 77(14):8072-86. PubMed ID: 12829846
[TBL] [Abstract][Full Text] [Related]
25. ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Li X; Du S; Avey D; Li Y; Zhu F; Kuang E
J Virol; 2015 Jul; 89(13):6895-906. PubMed ID: 25903346
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody.
Chan SR; Bloomer C; Chandran B
Virology; 1998 Jan; 240(1):118-26. PubMed ID: 9448696
[TBL] [Abstract][Full Text] [Related]
27. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
28. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus.
Cohen A; Brodie C; Sarid R
J Gen Virol; 2006 Apr; 87(Pt 4):795-802. PubMed ID: 16528027
[TBL] [Abstract][Full Text] [Related]
29. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
30. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome.
Choi JK; Lee BS; Shim SN; Li M; Jung JU
J Virol; 2000 Jan; 74(1):436-46. PubMed ID: 10590133
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
Wu FY; Wang SE; Tang QQ; Fujimuro M; Chiou CJ; Zheng Q; Chen H; Hayward SD; Lane MD; Hayward GS
J Virol; 2003 Aug; 77(16):8893-914. PubMed ID: 12885907
[TBL] [Abstract][Full Text] [Related]
32. Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus.
Zoeteweij JP; Moses AV; Rinderknecht AS; Davis DA; Overwijk WW; Yarchoan R; Orenstein JM; Blauvelt A
Blood; 2001 Apr; 97(8):2374-80. PubMed ID: 11290600
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus.
Davis DA; Rinderknecht AS; Zoeteweij JP; Aoki Y; Read-Connole EL; Tosato G; Blauvelt A; Yarchoan R
Blood; 2001 May; 97(10):3244-50. PubMed ID: 11342455
[TBL] [Abstract][Full Text] [Related]
34. Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.
Morris TL; Arnold RR; Webster-Cyriaque J
J Virol; 2007 Jun; 81(11):6032-42. PubMed ID: 17376930
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of lytic reactivation of Kaposi's sarcoma-associated herpesvirus by alloferon.
Lee N; Bae S; Kim H; Kong JM; Kim HR; Cho BJ; Kim SJ; Seok SH; Hwang YI; Kim S; Kang JS; Lee WJ
Antivir Ther; 2011; 16(1):17-26. PubMed ID: 21311105
[TBL] [Abstract][Full Text] [Related]
36. Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus.
Douglas J; Dutia B; Rhind S; Stewart JP; Talbot SJ
J Virol; 2004 Aug; 78(16):8878-84. PubMed ID: 15280496
[TBL] [Abstract][Full Text] [Related]
37. Transient expression of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication.
Caselli E; Galvan M; Cassai E; Di Luca D
Intervirology; 2003; 46(3):141-9. PubMed ID: 12867751
[TBL] [Abstract][Full Text] [Related]
38. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
[TBL] [Abstract][Full Text] [Related]
39. Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.
Sousa-Squiavinato AC; Silvestre RN; Elgui De Oliveira D
Rev Med Virol; 2015 Sep; 25(5):273-85. PubMed ID: 26192396
[TBL] [Abstract][Full Text] [Related]
40. Optimization of chemical induction conditions for human herpesvirus 8 (HHV-8) reactivation with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) from latently-infected BC-3 cells.
Ma W; Galvin TA; Ma H; Ma Y; Muller J; Khan AS
Biologicals; 2011 May; 39(3):158-66. PubMed ID: 21470875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
